Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another Pandemic

Presidential Perspective

Register


C. Warren OlanowSpeaker:
C. Warren Olanow MD, FRCPC, FRCP (hon)
Clintrex Research Corp, Mount Sinai School of Medicine, New York City, New York, USA

Webinar Topic:
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another Pandemic


Webinar Description:
A disease modifying therapy for PD is the major unmet therapeutic need in this disorder. Despite the many promising targets and candidate therapies, many pharmaceutical companies are abandoning this field because of the development costs and regulatory uncertainties. The lecture describes a new approach that Dr. Olanow believes can overcome these problems.

Learning Objectives:

  1. Be familiar with obstacles to development of a putative disease modifying therapy for PD 
  2. Know the clinical designs that have been used to date to try and define a disease modifying therapy
  3. Appreciate a new approach to developing disease modifying therapies for PD

Target Audience:
Movement disorder specialists, neurologists, individuals in the biotech and pharmaceutical industry who are potentially interested in developing disease modifying therapies for PD

This lecture will be made available for on-demand viewing starting on February 3, 2021.